Alveolar hemorrhage following allogeneic hematopoietic cell transplantation using reduced-intensity conditioning

Bone Marrow Transplantation

Volumn 38, Issue 11, 2006, Pages 765-768

  Majhail, N S ^a   Parks, K ^a   Defor, T E ^a   Weisdorf, D J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FLUDARABINE; METHYLPREDNISOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; INCIDENCE; LUNG HEMORRHAGE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; REDUCED INTENSITY CONDITIONING; WHOLE BODY RADIATION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; BONE MARROW TRANSPLANTATION; FEMALE; HEMATOLOGIC NEOPLASMS; HEMORRHAGE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; PULMONARY ALVEOLI; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 33751032678     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705521     Document Type: Article

References (13)

1. Afessa B, Tefferi A, Litzow MR, Peters SG. Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Resp Crit Care Med 2002; 166: 1364-1368.
2. Majhail NS, Parks K, DeFor T, Weisdorf DJ. Diffuse alveolar hemorrhage (DAH) and infection associated alveolar hemorrhage (IAH) following hematopoietic stem-cell transplantation: Related and high risk clinical syndromes with poor response to high-dose corticosteroids. Biol Blood Marrow Transplant 2006; 12 (Suppl 1): 133-134.
3. Lewis ID, DeFor T, Weisdorf DJ. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: Cryptic etiology and uncertain therapy. Bone Marrow Transplant 2000; 26: 539-543.
4. Afessa B, Tefferi A, Litzow MR, Krowka MJ, Wylam ME, Peters SG. Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Resp Crit Care Med 2002; 166: 641-645.
5. Baron F, Maris MB, Sandmaier BM, Storer BE, Sorror M, Diasonescu R et al. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J Clin Oncol 2005; 23: 1993-2003.
6. Maris MB, Niederwieser D, Sandmaier BM, Storer B, Stuart M, Maloney D et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood 2003; 102: 2021-2030.
7. Lin DY. Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 1997; 16: 901-910.
8. Snedecor GW, Cochran WG. Statistical Methods, 8th edn. Iowa State University Press: Ames, 1989, p 503.
9. Kaplan EL, Meier P. Nonparametric estimations from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
10. Agusti C, Ramirez J, Picado C, Xaubet A, Carreras E, Ballester E et al. Diffuse alveolar hemorrhage in allogeneic bone marrow transplantation. A postmortem study. Am J Resp Crit Care Med 1995; 151: 1006-1010.
11. Roychowdhury M, Pambuccian SE, Aslan DL, Jessurun J, Rose AG, Manivel JC et al. Pulmonary complications after bone marrow transplantation: An autopsy study from a large transplantation center. Arch Pathol Lab Med 2005; 129: 366-371.
12. Weisdorf DJ. Diffuse alveolar hemorrhage: An evolving problem? Leukemia 2003; 17: 1049-1050.
13. Blatt J, Gold SH, Wiley JM, Monahan PE, Cooper HC, Harvey D. Off-label use of recombinant factor VIIa in patients following bone marrow transplantation. Bone Marrow Transplant 2001; 28: 405-407.